Medline.ru - | Бронхиальная астма и табакокурение

Reference list

1. Antonov N.S. Epidemiologiya bronholegochnih zabolevanii v Rossii // Pylmonologiya, 2006.-4.-83-8;

2. Belevskii A.S. Test kontrolya astmi – «novaya igryshka» ili vajnii instryment // Atmosfera. Pylmonologiya i allergologiya, 2005.-1.-33-4;

3. Bilichenko T.N., Baldyeva M.F. Znachimost izmereniya okisi azota vidihaemogo vozdyha pri boleznyah organov dihaniya // Pylmonologiya, 2006.-6.- 118-22;

4. Bilichenko T. N. Bronhialnaya astma. Pod red. A. G. Chychalina, M.: 1997.-458;

5. Brimkylov N.N., Vinnikov D.V. Osobennosti tabachnoi zavisimosti y pacientov s hronicheskoi obstryktivnoi boleznu legkih // Pylmonologiya, 2002.-№4.-21-4;

6. Vinickaya R.S. Kapnografiya v diagnostike lyogochnoi nedostatochnosti, 2002.- http://www.medlinks.ru/article.php?sid=5835;

7. Geppe N.A. Sovremennie predstavleniya o taktike lecheniya bronhialnoi astmi y detei // RMJ, 2002.- t.10. -7.- 353-58;

8. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. Peresmotr 2006. Rysskaya versiya pod redakciei akademika RAMN Chychalina A.G. M.: «Atmosfera», 2007.-1-160;

9. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. Peresmotr 2007. Rysskaya versiya pod redakciei akademika RAMN Chychalina A.G. M.: «Atmosfera», 2008.-1-160;

10. Globalnaya strategiya lecheniya i profilaktiki bronhialnoi astmi. (Global Initiative for Asthma, GINA), peresmotr 2009 g. (http://www.ginasthma.org.);

11.Gnoevih V.V. Effektivnost adaptacii respiratornoi sistemi k kyreniu y stydentov medicinskih vyzov pri nikotinassociirovannom riske hronicheskoi obstryktivnoi bolezni legkih // Pylmonologiya, 2005.- t.15.-№3.-69-73;

12. Gnoevih V.V. Nikotininassociirovannie osobennosti kachestva jizni y bolnih bronhialnoi astmoi molodogo vozrasta/V.V. Gnoevih, V.A. Semenov, E.A. Shalashova // Izvestiya visshih ychebnih zavedenii. Povoljskii region. Seriya «Medicinskie nayki», 2006.-№ 1 (22).-81-91;

13. Gnoevih V.V. Disfynkcii pylmo-kardialnoi sistemi pri tabakokyrenii y lic molodogo vozrasta i hronicheskie obstryktivnie zabolevaniya lyogkih // Avtoref. diss. na soiskanie ych. st. doktora med. nayk, Ylyanovsk, 2007.-41 str.;

14.Gnoevih V.V. Matematicheskoe modelirovanie rannih nikotinassociirovannih disfynkcii pylmo-kardialnoi sistemi na nachalnih etapah razvitiya HOBL // Pylmonologiya, 2007.-№2.- 63-7;

15. Gnoevih V.V. Hronicheskaya obstryktivnaya bolezn lyogkih. Izdanie dlya praktikyushih vrachei i issledovatelei: monografiya.-Ylyanovsk: YlGY, 2007.-ISBN 978-5-88866-276-2.-174 str.;

16. Gnoevih V.V. Nozologicheskie posledstviya tabakokyreniya sredi lic molodogo vozrasta/V.V. Gnoevih, V.A. Semyonov, A.U. Smirnova, E.A. Shalashova, L.A. Besova, A.A. Kypriyanov, M.U. Zverev, R.M. Hairetdinova // Vestnik novih medicinskih tehnologii, 2008.-t. XV.- №2.-110-12;

17.Gnoevih V.V. Disfynkcii kardiorespiratornoi sistemi pri tabakokyrenii y lic molodogo vozrasta/V.V. Gnoevih, S.P. Grigorev, O.V. Aleksandrov, V.A. Semyonov, A.U. Smirnova, A.A. Kypriyanov, R.M. Hairetdinova // Rossiiskii medicinskii jyrnal, 2008.-№4.-13-7;

18.Gnoevih V.V. Disfynkcii pylmokardialnoi sistemi y lic molodogo vozrasta v processe adaptacii k tabakokyreniu // Klinicheskaya fiziologiya krovoobrasheniya, 2008.-№2.-53-62;

19. Golovochesova G.A. Analiz osnovnih prichin nekontroliryemogo techeniya bronhialnoi astmi // Sibirskii medicinskii jyrnal, 2009, № 4.-128-30;

20.Grippi M.A. Patofiziologiya legkih: Per. s angl. Pod red. U.V. Natochina.-M.: Binom; 1997.109-53;

21.Emelyanov A.V., Fedoseev G.B., Sergeeva G.R., Ivanova N.I., Zibrina T.M. i dr. Rasprostranennost bronhialnoi astmi i allergicheskogo rinita sredi vzroslogo naseleniya Sankt-Peterbyrga. // Allergologiya. 2002. №2.-10-5;

22. Zaridze D.G. Kyrenie - osnovnaya prichina visokoi smertnosti rossiyan/ D.G. Zaridze, R.S. Karpov, S.M. Kiseleva i dr. // Vestnik RAMN, 2002.- №9.-40-5;

23. Zdorove lyogkih v Evrope»: fakti i cifri. Adaptirovannaya versiya «White Book»/per. A.G. Chychalina, N.S. Antonova, E. Koryaginoi, 2003;

24.Ivchik T.V. Faktori riska hronicheskoi obstryktivnoi bolezni lyogkih/ T.V. Ivchik, A.N. Kokosov, E.D. Yanchina i dr. // Pylmonologiya, 2003.-t. 13.-№3.-6-15;

25.Ivanov A.F., Chernyak B.A. Pokazateli kontrolya bronhialnoi astmi i ih vzaimosvyaz s nespecificheskoi giperreaktivnostu bronhov y molodih bolnih // Pylmonologiya, 2007.-№5.-19-23;

26.Karpyshkina A.V., Geppe N.A., Kondurina E.G., Korostovcev D.S, Malahov A.B. i dr. Mnogocentrovoe otkritoe randomizirovannoe kliniko-ekonomicheskoe issledovanie razlichnih rejimov farmakoterapii pri lechenii srednetyajeloi i tyajeloi bronhialnoi astmi y detei // Allergologiya, 2004.-№3.-24-32;

27. Knyajeskaya N.P. Osnovnie principi diagnostiki, klassifikacii i lecheniya bronhialnoi astmi // Consillium-medicum, 2006.-t. 8.-№3;

28.Knyajeskaya N.P. Legkaya persistiryushaya astma: voprosi diagnostiki, lecheniya i kontrolya // Atmosfera. Pylmonologiya i allergologiya, 2006.-№4.-26-30;

29.Kompleksnoe lechenie tabachnoi zavisimosti i profilaktika hronicheskoi obstryktivnoi bolezni lyogkih, vizvannoi kyreniem tabaka. Metodicheskie rekomendacii Ministerstva zdravoohraneniya i socialnogo razvitiya RF №2002/154. M., 2003;

30.Klinicheskie rekomendacii. Bronhialnaya astma. Pod red. akademika RAMN Chychalina A.G. Moskva: Atmosfera, 2008.-224;

31. Kycenko S. A Osnovi toksikologii, 2003.-t. 4.-119;

32. Leshenko I.V. Rasprostranennost bronhialnoi astmi v Sverdlovskoi oblasti// Pylmonologiya, 2001.- 2.- 50-5;

33.Lygovskaya S.A., Pochtar M.E., Dolgov V.V. Gematologicheskie analizatori. Interpretaciya analizov krovi. Metod. rekomendacii. M.: «Triada», 2007.-17-103;

34. Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih (HOBL): diagnostika i lechenie // Consilium Medicum, 2004.-t.6.-№1;

35. Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih: terapiya pri stabilnom techenii // Consilium Medicum, 2006.-t.8.-№3.-66-70;

36.Ogorodova L. M., Deev I. A., Selivanova P. A. GINA 2006: Kontrol astmi kak osnovnaya cel lecheniya i kriterii effektivnosti terapii // Pylmonologiya, 2007. – № 6.– 42 – 45.

37.Privalova E.V., Vavilova T.V., Kyzybova N.A. Morfofynkcionalnie harakteristiki eritrocitov y kyrilshikov s obstryktivnoi boleznu legkih // Pylmonologiya, 2008.- №6.- 48 -52;

38.Rakita D.D. Vliyanie kyreniya na techenie hronicheskoi obstryktivnoi bolezni lyogkih // Diss. na soiskanie ych. st. kand. med.nayk, Ryazan, 2004.-124 s.;

39.Rydkevich M.V. stohasticheskaya imitacionnaya model odnogo mehanizma pylmo-kardialnoi sistemi. Diss. na soiskanie ych. st. kand. f.-m.n. Ylyanovsk, 2005.-104s.;

40.Sinopalnikov A.I. Infekcionnoe obostrenie hronicheskoi obstryktivnoi bolezni lyogkih/A.I. Sinopalnikov, A.G. Romanovskih // Atmosfera. Pylmonologiya i allergologiya, 2006.-№3.-15-22;

41. Soodaeva S.K. Okislitelnii stress i antioksidantnaya terapiya pri zabolevaniyah organov dihaniya // Pylmonologiya, 2006.-5.-122-26;

42. Soodaeva S.K. Oksidantnie i antioksidantnie sistemi legkih pri hronicheskih obstryktivnih zabolevaniyah. V kn.: Hronicheskie obstryktivnie bolezni legkih. M.: «Binom»; 1998.-92–110;

43. Soodaeva S.K., Lisica A.V., Kybisheva N.I. i dr. Perspektivi primeneniya antioksidantov v klinike vnytrennih boleznei. «Atmosfera», 2004; 1(12): 55–6;

44. Yest Dj. Fiziologiya dihaniya. Osnovi.-M.-«Mir», 1988.-200 s.;

45.Fedoseev G.B., Trofimov V.I. Bronhialnaya astma. SPB.: Nordmedizdat, 2006;

46.Federalnaya celevaya programma «Bronhialnaya astma» 2011-2015 godi). M., 2009;

47. Chychalin A.G. Hronicheskie obstryktivnie bolezni lyogkih. M.: Binom, 1999.-512 s.;

48. Chychalin A.G. Prakticheskoe rykovodstvo po lecheniu tabachnoi zavisimosti/ A.G. Chychalin, G.M. Saharova, K.U. Novikov // RMJ, 2001.-t.9.-№21.-904-11;

49.Chychalin A.G., Coi A.N., Arhipov V.V., Gavrishina E.E. Bronhialnaya astma v Rossii: rezyltati nacionalnogo issledovaniya kachestva medicinskoi pomoshi bolnim bronhialnoi astmoi // Pylmonologiya, 2006, №6.-94-102;

50.Coi A.N., Arhipov V.V., Chapyrin S.A. Farmakoekonomicheskoe issledovanie novoi koncepcii primeneniya simbikorta y bolnih bronhialnoi astmoi // Pylmonologiya, 2007.-№3.-34- 40;

51. Shalashova E.A. Diagnostika rannih izmenenii fynkcionalnogo sostoyaniya kardio- respiratornoi sistemi y bolnih bronhialnoi astmoi //Avtoreferat diss. na soiskanie ych. stepeni k. m. n., Ylyanovsk, 2006.-24 str.;

52.Shmidt R. Fiziologiya cheloveka. Per. s angl. pod red. Kostuka P.G./R. Shmidt, G. Tevs. M.: «Mir», 1996;

53. Asthma. European Respiratory Monograph 23/Edited by Chung F., Fabbri L.M., European Respiratory Society J., 2003.-V. 8.-458 pp.;

54. Bakke P.S. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: A Norwegian Community Study/ P.S. Bakke, R. Hanoa, A. Gulsvik // Am. J. Epidemiol., 1995.-141.-1080-88;

55. Baraldi E., Azzolin N.M., Biban P., Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis // Am. J. Respir. Crit Care Med., 1997.-155.-1583– 1680;

56. Barnes P. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids// Eur Respir J, 2002.-19.-182–91;

57. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline_defined asthma control be achieved? The Gaining Optimal Asthma ControL study // Am. J. Respir. Crit. Care Med., 2004.-170(8).-836-44;

58. Bisgaard H., Loland L., Oj J.A. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast // Am. J. Respir. Crit. Care Med., 1999.- 160.-1227–231;

59. Beasley R. The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). Available from http://www.ginasthma.org, 2004;

60.Beckman J.S. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly/ J.S. Beckman, W.H. Koppenol // Am. J. Physiol., 1996.-271.-1432–37;

61. Boulet L-P, Boulet V, Milot J. How should we quantify asthma control? // Chest, 2002.-122.-2217- 23;

62. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling // Am. J. Respir. Crit. Care Med., 2000.-161(5):1720-45;

63. Boychuk R.B ., Yamamoto L.G, De Mesa C.J., Kiyabu K.M. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization // Am. J. Emerg. Med., 2006 Jan.-24(1).-48-52;

64. Bowler R.P. The role of oxidative stress in chronic obstructive pulmonarydisease/ R.P. Bowler, P.J. Barnes, J.D. Crapo // J. COPD, 2004.-2.-255–77;

65. Brannan J.D. Bronchial hyperresponsiveness in the assessment of asthma control: Airway hyperresponsiveness in asthma: its measurement and clinical significance // Chest, 2010.-138(2 Suppl).-11S-7S;

66.Campbell J.D., Blough D.K., Sullivan S.D. Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma // Ann. Allergy Asthma Immunol, 2008.-101.-474–81;

67. Cerveri I., Accordini S., Corsico A., et al. Chronic cough and phlegm in young adults // Eur. Respir. J., 2003.-22.-13–417;

68. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma // Thorax, 2002.-57.-226– 30;

69. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma // Thorax, 2002.-57.-226– 30;

70. Chandra R. The Effects of Cigarette Smoking on Anesthesia // Anesth. Prog., 2000.- 47.-143-50;

71. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma // Am. J. Respir. Crit. Care Med., 2003.-168.-1308–11;

72. Coburn R.F. Carbon monoxide toxicity // In Fahri L.E., Tenney S.M. (eds.) Handbook of Physiology, Sect. 3: The Respiratory System, Vol. IV. Bethesda. Amer. Physiology Soc., 1987.- 176-94;

73. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression // Ann. Rev. Immunol., 2004.-22.-789-815;

74. Convery R., Leitch D., Bromly C., Ward R., Bartlett G., Hendrick D. Effect of inhaled fluticasone proprionate on airway responsiveness in treatment-naive individuals: a lesser benefit in females // Eur. Respir. J., 2000.-15.-19–24;

75. Coultas D. Passive smoking and risk of adult asthma and COPD: an update // Thorax, 1998.-53.-381- 87;

76.Davidson J.A.H., Hosie H.E. Limitations of pulse oximetry: respiratory insufficiency - a failure of detection // BMJ, 1993.-307.-372-73;

77.Dixon A.E. Asthma in American Indian adults: the Strong Heart Study // Chest, 2007.-131(5).- 1323-30;

78.Ehrich R.I. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking/ R.I. Ehrich, D. Toit, E. Jordaan et al. // Am. J. Respir. Crit. Care Med., 1996.-154.-681-8;

79.Eggleston P.A. The environment and asthma in US inner cities // Chest, 2007; 132(5 Suppl)/- 782-8;

80. Environmental tobacco smoke: a hazard to children. American Academy of Pediatrics Committee on Environmental Health // Pediatrics, 1997.-99.-639-42;

81. Fagerstrom K. O./K.O. Fagerstrom, U. Sawe // Cardiovasc. Risk Factor, 1997.-Vol. 6.-№3.- 135

82. Fearnley S.J., Manners J.M. Pulse oximetry artifact in a patient with a right ventricular myxoma // Anaesthesia, 1993.-48(1).-87-8;

83.Ferrence R. Protecting children from passive smoking/R. Ferrence, M.J. Ashley // BMJ, 2000.-321.- 310-311;

84. Gerald L.B. Changes in environmental tobacco smoke exposure and asthma morbidity among urban school children // Chest, 2009.-135(4).-911-6;

85.Gilliland F.D. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function/F.D. Gilliland, K. Berhane, R. McConnell et al. // Thorax, 2000.-55.-271- 276;

86. Godtfredsen N.S. Changes in smoking habits and risk of asthma: a longitudinal population based study/N.S. Godtfredsen, P. Lange, E. Prescott et al. // Eur. Respir. J., 2001.-18.-549-54;

87. Groneberg D.A., Quarcoo D., Frossard N., Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases // Allergy, 2004.-59(11).-1139.-52;

88. Horváth I ., Donnelly L.E., Kiss A., Paredi P., Kharitonov S.A., Barnes P.J. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress // Thorax, 1998 Aug.-53(8).-668- 72;

89. Higenbottam T.W ., Feyeraband C., Clark T.J. Cigarette smoking in asthma // Br. J. Dis. Chest, 1980 Jul.-74(3).-279-84;

90. Hutton P., Clutton-Brock T. The benefits and pitfalls of pulseoximetry // BMJ, 1993.-307.-457- 458;

91. Ilowite J., Bennett W., Sheetz M., Groth M., Nierman D. Permeability of the bronchial mucosa to 99mTc-DTPA in asthma // Am Rev Respir Dis, 1988.-139.-1139–43;

92. James A. Airway remodeling in asthma // Curr Opin Pulm Med, 2005.-11(1).-1.-6;

93.Jarvis M.J. Expired air carbon monoxide: a simple breath test of tobacco smoke intake/ M.J. Jarvis, M.A. Russel, Y. Saloojee // BMJ, 1980.-281.-484-5;

94. Jindal S.K. The relationship between tobacco smoke & bronchial asthma/ S.K. Jindal, D.Gupta // Indian J. Med. Res., 2004.-Vol. 120(5).-443-53;

95.Kaiser H., Schoetzau A., Flammer J. Blood flow velocity in the extraocular vessels in chronic smokers // Br. J. Ophthalmol., 1997.-81.-133–5;

96. Kharitonov S.A. Acute and chronic effects of cigarette smoking on exhaled nitric oxide/S.A. Kharitonov, R.A. Robbins, D. Yates et al. // Am. J. Respir. Crit. Care Med., 1995.-152(2).-609-12;

97.Kerstens H.A.M. Decline of EFV1 by age and smoking status: facts, figures an fallacies/H.A.M. Kerstens, B. Rijcken, J.P. Schouten et al. // Thorax, 1997.-52.-820-7;

98.Ko F.W., Wang H.Y., Wong G.W., Leung T.F., Hui D.S., Chan D.P., et al. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community_based study in Hong Kong and Guangzhou // Clin. Exp. Allergy, 2005.-35(11).-1449-56;

99. Kogevinas, Anto M., Soriano J.M., Tobia A. The risk of asthma attributable to occupantional exposures: a population based study in Spain (Spanish Group of the Europian Asthma Study) // Am. J. Resp. and Crit. Care Med., 1996.-154.-137-43;

100. Kelly A.M., McAlpine R., Kyle E. How accurate are pulse oximeters in patients with acute exacerbations of COPD? // Resp. Med., 2001.-95.-336–40;

101. Kuschner W.G. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults/W.G. Kuschner, A. D'Alessandro, H. Wong et al. // Eur. Respir. J., 1996.-9(10).-1989-94;

102. Lai C.K., De Guia T.S., Kim Y.Y., Kuo S.H., Mukhopadhyay A., Soriano J.B., et al. Asthma control in the Asia_Pacific region: the Asthma Insights and Reality in Asia_Pacific Study // J. Allergy Clin. Immunol., 2003.-111(2).-263-8;

103. Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A 15 year follow-up study of ventilatory function in adults with asthma // N Engl J Med, 1998.-339.-1194–200;

104. Laustiola K., Lassilia R., Kaprio J., Koskenvuo M. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers: a study of monozygotic twin pairs discordant for smoking // Circulation, 1988.-78.-1234–40;

105. Lenney W. The burden of pediatric asthma // Pediatr Pulmonol Suppl, 1997.-15.-13-6;

106. Levy M.L. Guideline-defined asthma control: a challenge for primary care // Eur. Respir., 2008.- 31.-229–31;

107. Lee P.J., Alam J., Sylvester S.L., Inamdar N., Otterbein L., Choi A.MK. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury // Am. J. Respir. Cell Mol. Biol., 1996.-14.- 556.-68;

108. Lindberg S., Cervin A., Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis // Acta Otolaryngol., 1997.-117.-113–17;

109. Lindstrom M. Smoking, respiratory symptoms and diseases/ M. Lindstrom, J. Kotaniemi, E. Jonson et al. // Chest, 2001.-119.-852–861;

110. Mancuso C.A. Patient-reported and physician-reported depressive conditions in relation to asthma severity and control // Chest, 2008.- 133(5).- 1142-8;

111. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report // Allergy, 2004.-59(5).-469-78;

112. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol., 2001.- 429.-195–207;

113. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity // Chest, 2002.-5(Suppl).-121S-6S;

114. Management of Chronic Obstructive Pulmonary Disease Eur. Respir. Monograph 38/Edited by Siafakas N.M. // European Respiratory Society J, 2006.-V. 11.-475 pp.;

115.Maneechotesuwan K. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils // Chest, 2007.-132(1).-98-105;

116.Miller A.L., Lukacs N.W. Chemokine receptors: understanding their role in asthmatic disease // Immunol Allergy Clin. North. Am., 2004.-24(4).-667-83;

117.Moyle J.T.B. Pulseoximetry. Principles and Practice Series. Editors: Hahn C.E.W. and Adams A.P. // BMJ Publishing, London, 1994;

118.Montuschi P. Isoprostanes: markers and mediators of oxidative stress/ P. Montuschi, P.J. Barnes, L.J. Roberts // FASEB J., 2004.-18.-1791–800;

119.Nafstad P., Kongerud J., Botten G., Hagen J.A., Jaakkola J.J. The role of passive smoking in the development of bronchial obstruction during the first 2 years of life // Epidemiology, 1997.-8(3).-

120.Nathan RA, Sorkness CA, Kosinski M, Schatz M, et al. development of asthma control test: a survery for assessing asthma control // J Allergy and Clinical Immunology, 2004.- 113. -59-65;

121.Neffen H., Fritscher C., Schacht F.C., Levy G., Chiarella P., Soriano J.B., et al. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey // Rev. Panam Salud Publica, 2005.-17(3).-191-7;

122. Newman R.B. The effect of active and passive household cigarette smoke exposure on pregnant women with asthma // Chest .-2010.-137(3).- 601-8;

123.Paredi P., Leckie M.J., Horvath I., Allegra L., Kharitonov S.A., Barnes P.J. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma // Eur Respir J, 1999.-13.-48-52;

124.Pellegrino R.. Assessing the reversibility of airway obstruction/ R. Pellegrino, J.R. Rodarte, V. Brusasco // Chest, 1998.-114.-1607-12;

125.Pedersen B., Dahl R., Karlstrom R., Peterson C., Venge P. Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide // Am. J. Respir. Crit. Care Med., 1996.-153.- 1519–29;

126.Piipari R.. Smoking and asthma in adults/ R. Piipari, J.J.K. Jaakkola, N.J Jaakkola et al. // Eur. Respir. J., 2004.-24(5).-734-39;

127.Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in (AIRE) Study // Eur. Respir. J., 2000.-16.- 802–7;

128. Rahman I , Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers // Am. J. Respir. Crit . Care Med ., 1996 Oct.-54(4 Pt 1).-1055-60;

129. Ramírez-Prieto MT , García-Río F, Villamor J. Role of oxidative stress in respiratory diseases and its monitoring // Med Clin (Barc), 2006 Sep 16.-127(10).-386-96;

130. Ramsdale E. H., Morris M. M., Roberts R. S., Hargreave F. E. Asymptomatic bronchial hyperresponsiveness in rhinitis // J. Allergy Clin. Immunol, 1985.- 75.- 73-7;

131.Robbins R.A., Barnes P.J., Springall D.R., et al. Expression of inducible nitric oxide in human lung epithelial cells // Biochem. Biophys. Res. Commun., 1994.-203.-209–18;

132.Sadowska A.M., van Overveld F.J., Gorecka D. et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant // Respir. Med., 2005.-99.-241–49;

133. Saetta M. CD8zT-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease/M. Saetta, A. Di Stefano, G. Turato, et al. // Am. J. Respir. Crit. Care Med., 1998.-157.- 822–826;

134.Sinex, J. Pulse oximetry: principles and limitations // Am J Emerg Med., 1999.-17(1).-59–67;

135.Siroux V, Pin I, Oryszcyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study // Eur. Respir. J., 2000.-15.-470–77;

136.Shatz M., Zeigert R.S., Vollmer W.M. Predictors of future long-term asthma control // J. Allergy and Clinical Immunology, 2006.-118.-1048;

137.Sherwood N. Effects of nicotine on human psychomotor performance // Human Psychopharmacology.: Clinical and Experimental, 1993.-Vol. 8.-155-84;

138.Soubani A.O. Noninvasive monitoring of oxygen and carbon dioxide // Am. J. Emerg. Med., 2001.- 19(2).-141–46;

139. Soyseth V., Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness of atopy of their children/ V. Soyseth, J. Kongerud, J. Boe // Chest, 1995.- 107(2).-389-94;

140. Stoneham M.D.,Saville G.M.,Wilson I.H. Knowledge about pulse oximetry among medical and nursing staff // Lancet, 1994.-334.-1339-42;

141. Tillie-Leblond I.,Gosset P., Tonnel A.B. Inflommantory events in severe acute asthma // Allergy, 2005.- V.60.- 1.- 23-9;

142.Thomson N.C., Chaudhuri R., Livingston E. Asthma and cigarette smoking // Eur. Respir J, 2004.- 24.-822-33;

143. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities // Curr Opin Pulm Med, 2009.-15.-39–45;

144.Trofor A. Health disorders related to tobacco use and passive smoking // ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

145.Trofor A. Polyaddictions Part I // ERS Learning Resources: Smoking cessation, Bucharest, 2004. - http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

146.Van de Louw A./A. Van de Louw , C. Cracco, C. Cerf et al. // Intens. Care Med.-2001.-27.-1606-13;

147.Wahlgren D.R. Involuntary smoking and asthma/D.R. Wahlgren, M.F. Hovell, E.O. Meltzer et al. // Curr. Opin. Pulm. Med., 2000.-6.-31-6;

148.Weitzman M. Maternal smoking and childhood asthma/ M. Weitzman, S. Gortmaker, D.K. Walker et al. // Pediatrics, 1990.-85.-505-11;

149.Willis D, Moore AR, Frederick R,Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response // Nature Med, 1996.-2.-87-90;

150.Woodcock AA, Bagdonas A, Boonsawat W, Gibbs MR, Bousquet J, Bateman ED. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone // Prim Care Respir J, 2007.-16.-155–161;

151.Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., Rahman I. Sirtuin regulates cigarette smoke–induced pro–inflamotory mediator release via RelA/p65 NF–kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging // Am. J Physiol Lung Cell Mol Physiol, 2007.- 292.-567–76;

152. Zayasu K , Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients // Am J Respir Crit Care Med., 1997 Oct.-156(4 Pt 1).-1140-3.